Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Belgium.
Eur J Hum Genet. 2009 Nov;17(11):1403-10. doi: 10.1038/ejhg.2009.56. Epub 2009 Apr 15.
Preimplantation genetic diagnosis (PGD) is an alternative to prenatal diagnosis for patients at risk of transmitting an inherited disease such as myotonic dystrophy type 1(DM1) to their offspring. In this paper, the clinical application of preimplantation diagnosis for DM1 upon request to children born is described in a large cohort of risk couples. PGD could be offered to all 78 couples opting for PGD regardless of the triplet repeat size. The incidence of major complications was minimalised following a careful assessment in affected DM1 females anticipating possible cardiological, obstetrical and anaesthetical problems. A live-birth delivery rate per cycle with oocyte retrieval of 20% was the outcome. Forty-eight of the 49 children born are in good health and have normal psychomotor development.
胚胎植入前遗传学诊断(PGD)是一种替代产前诊断的方法,适用于有遗传疾病风险的患者,如肌强直性营养不良 1 型(DM1),向其后代传递。本文描述了在请求对出生的儿童进行 DM1 胚胎植入前诊断的情况下,对大量风险夫妇的临床应用。无论三核苷酸重复序列大小如何,所有选择 PGD 的 78 对夫妇都可以提供 PGD。通过仔细评估可能存在的心血管、产科和麻醉问题,最大限度地减少了受影响的 DM1 女性中主要并发症的发生率。每个取卵周期的活产分娩率为 20%。49 名出生的儿童中有 48 名身体健康,精神运动发育正常。